New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed 21-09-2025, 09:15

Industry, Webuild: activities continue unabated at ‘underwater’ construction site of the new breakwater in Genoa 17-07-2023, 22:08

Nature’s Sunshine Sets Fourth Quarter and Full Year 2022 2-03-2023, 04:09